Menatetrenone

Share on Facebook Share on Twitter Email
Top
Menatetrenone
Systematic (IUPAC) name
2-methyl-3-[(2Z,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]naphthoquinone
Clinical data
AHFS/Drugs.com International Drug Names
Pregnancy cat.  ?
Legal status  ?
Routes Oral
Identifiers
CAS number 863-61-6
ATC code None
PubChem CID 5282367
UNII 27Y876D139 YesY
KEGG D00100 YesY
Synonyms 3-methyl-2-[(2Z,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]naphthalene-1,4-dione
Chemical data
Formula C31H40O2 
Mol. mass 444.648 g/mol
 YesY (what is this?)  (verify)

Menatetrenone (INN), also known as MK4, is a menaquinone compound used as a hemostatic agent and as adjunctive therapy for the pain of osteoporosis. It is marketed for the latter indication in Japan by Eisai Co., under the trade name Glakay.

Menatetrenone (MK4) is one of the nine forms of vitamin K2.[1]

MK4 is produced via conversion of vitamin K1 in the body, in the testes, pancreas and arterial walls.[2] While major questions still surround the biochemical pathway for the transformation of vitamin K1 to MK4, studies demonstrate the conversion is not dependent on gut bacteria, occurring in germ-free rats[3][4] and in parenterally-administered K1 in rats.[5][6] In fact, tissues that accumulate high amounts of MK4 have a remarkable capacity to convert up to 90% of the available K1 into MK4.[7][8]

See also

References

  1. ^ Iwamoto J, Takeda T, Sato Y (December 2006). "Menatetrenone (vitamin K2) and bone quality in the treatment of postmenopausal osteoporosis". Nutr. Rev. 64 (12): 509–17. doi:10.1111/j.1753-4887.2006.tb00184.x. PMID 17274493. http://openurl.ingenta.com/content/nlm?genre=article&issn=0029-6643&volume=64&issue=12&spage=509&aulast=Iwamoto. 
  2. ^ Sell, DR; Monnier VM (1990). "End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen". Journal of Clinical Investigation 85 (2): 380–384. doi:10.1172/JCI114449. PMC 296435. PMID 2298912. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=296435. 
  3. ^ Davidson, RT; Foley AL, Engelke JA, Suttie JW (1998). "Conversion of Dietary Phylloquinone to Tissue Menaquinone-4 in Rats is Not Dependent on Gut Bacteria1". Journal of Nutrition 128 (2): 220–223. PMID 9446847. 
  4. ^ Ronden, JE; Drittij-Reijnders M-J, Vermeer C, Thijssen HHW. (1998). "Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat". Biochimica et Biophysica Acta (BBA) - General Subjects 1379 (1): 69–75. doi:10.1016/S0304-4165(97)00089-5. PMID 9468334. 
  5. ^ Thijssen, HHW; Drittij-Reijnders MJ (1994). "Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4". British Journal of Nutrition 72 (3): 415–425. doi:10.1079/BJN19940043. PMID 7947656. 
  6. ^ Will, BH; Usui Y, Suttie JW (1992). "Comparative Metabolism and Requirement of Vitamin K in Chicks and Rats". Journal of Nutrition 122 (12): 2354–2360. PMID 1453219. 
  7. ^ Davidson, RT; Foley AL, Engelke JA, Suttie JW (1998). "Conversion of Dietary Phylloquinone to Tissue Menaquinone-4 in Rats is Not Dependent on Gut Bacteria". Journal of Nutrition 128 (2): 220–223. PMID 9446847. 
  8. ^ Ronden, JE; Drittij-Reijnders M-J, Vermeer C, Thijssen HHW (1998). "Intestinal flora is not an intermediate in the phylloquinone-menaquinone-4 conversion in the rat". Biochimica et Biophysica Acta (BBA) - General Subjects 1379 (1): 69–75. doi:10.1016/S0304-4165(97)00089-5. PMID 9468334. 

External links



Post a question - any question - to the WikiAnswers community:

Copyrights: